Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells

Circulation Research

Volumn 80, Issue 4, 1997, Pages 557-564

  Durante, William ^a,b   Kroll, Michael H ^a   Christodoulides, Nick ^a   Peyton, Kelly J ^a   Schafer, Andrew I ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

carbon monoxide; heme oxygenase; nitric oxide

Indexed keywords

8 BROMO CYCLIC GMP; CARBON MONOXIDE; CYCLOHEXIMIDE; DACTINOMYCIN; DIBUTYRYL CYCLIC GMP; HEME OXYGENASE; INTERLEUKIN 1BETA; LINSIDOMINE; N ACETYL S NITROSOPENICILLAMINE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

EID: 0030961521     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.80.4.557     Document Type: Article

References (49)

1. Tenhunen R, Marver HS, Schmidt R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A. 1968;244:6388-6394.
2. Maines MD, Trakshel GM, Kutty RK. Characterization of two constitutive forms of heme oxygenase: only one molecular species of the enzyme is inducible. J Biol Chem. 1986;261:411-419.
3. Trakshel GM, Maines MD. Multiplicity of heme oxygenase isozymes: HO-1 and HO-2 are different molecular species in rat and rabbit. J Biol Chem. 1989;264:1323-1328.
4. Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 1988;2:2557-2568.
5. Maines MD. Heme Oxygenase: Clinical Applications and Functions. Boca Raton, Fla: CRC Press; 1992.
6. Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH. Carbon monoxide: a putative neural messenger. Science. 1993;259:381-384.
7. Graser T, Vedernikov YP, Li DS. Study on the mechanism of carbon monoxide induced endothelium-independent relaxation in the porcine coronary artery and vein. Biomed Biochim Acta. 1990;49:293-296.
8. Ramos KS, Lin H, McGrath JJ. Modulation of cyclic guanosine monophosphate levels in cultured smooth muscle cells by carbon monoxide and nitric oxide. Biochem Pharmacol. 1989;38:1368-1370.
9. Brune B, Ullrich V. Inhibition of platelet aggregation by carbon monoxide is mediated by the activation of guanylate cyclase. Mol Pharmacol. 1987;32:497-504.
10. Levere RD, Martasek P, Escalante B, Schwartzman ML, Abraham NG. Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. J Clin Invest. 1990;86:213-219.
11. Johnson RA, Lavesa M, Askari B, Abraham NG, Nasjletti A. A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats. Hypertension. 1995;25:166-169.
12. Zakhary R, Gaine SP, Dinerman L, Ruat M, Flavahan NA, Snyder SH. Heme oxygenase-2: endothelial and neuronal localization and role in endothelium-dependent relaxation. Proc Natl Acad Sci U S A. 1996;93:795-798.
13. Loscalzo J, Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis. 1995;38:87-104.
14. Busse R, Mulsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett. 1990;275:87-90.
15. Beasley DJ, Schwartz JH, Brenner BM. Interleukin-1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest. 1991;87:602-608.
16. Christodoulides N, Durante W, Kroll MH, Schafer AI. Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation. 1995;91:2306-2309.
17. Morita T, Perella MA, Lee ME, Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci U S A. 1995;92:1475-1479.
18. Cook MN, Nakatsu K, Marks GS, McLaughlin BE, Vreman HJ, Stevenson DK, Brien JF. Heme oxygenase activity in the adult rat aorta and liver as measured by carbon monoxide production. Can J Physiol Pharmacol. 1995;73:515-518.
19. Durante W, Schini VB, Catovsky S, Kroll MH, Vanhoutte PM, Schafer AI. Plasmin potentiates the induction of nitric oxide synthase by interleukin-1β in vascular smooth muscle. Am J Physiol. 1993;264:H617-H624.
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
21. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76:4350-4354.
22. Lee ME, Temizer DH, Clifford JA, Quertermous T. Cloning of the GATA binding protein that regulates endothelin-1 gene expression in endothelial cells. J Biol Chem. 1991;266:16188-16192.
23. Shibahara S, Muller R, Taguchi H, Yoshida T. Cloning and expression of cDNA for rat heme oxygenase. Proc Natl Acad Sci U S A. 1985;82:7865-7869.
24. Rotenberg MO, Maines MD. Isolation, characterization, and expression of the cDNA for rat heme oxygenase. J Biol Chem. 1990;265:7501-7506.
25. Durante W, Kroll MH, Orloff GJ, Cunningham JM, Scott-Burden T, Vanhoutte PM, Schafer AI. Hemostatic proteins regulate intetleukin-1β stimulated inducible nitric oxide synthase expression in cultured vascular smooth muscle cells. Biochem Pharmacol. 1996;51:847-853.
26. Durante W, Schini VB, Kroll MH, Catovsky S, Scott-Burden T, White G, Vanhoutte PM, Schafer AI. Platelets inhibit the induction of nitric oxide synthesis by interleukin-1β in vascular smooth muscle cells. Blood. 1994;83:1831-1838.
27. Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry. 1988;27:8706-8711.
28. 15N]nitrate in biological fluids. Anal Biochem. 1982;126:131-138.
29. Greene YJ, Healey JF, Bonkovsky HL. Immunochemical studies of haem oxygenase: preparation and characterization of antibodies to chick liver haem oxygenase and their use in detecting and quantifying amounts of haem oxygenase protein. Biochem J. 1991;279:849-854.
30. Motterlini R, Foresti R, Intaglietta M, Winslow RM. NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol. 1996;270:H107-H114.
31. Tangelder GJ, Teirlinck HC, Slaaf DW, Reneman RS. Distribution of blood platelets flowing in arterioles. Am J Physiol. 1985;248:H318-H323.
32. Uijttewaal WS, Nijhof EJ, Bronkhorst PJ, Hartog ED, Heethaar RM. Near wall excess of platelets induced by lateral migration of erythrocytes in flowing blood. Am J Physiol. 1993;264:H1239-H1244.
33. Applegate LA, Luscher P, Tyrell RM. Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res. 1990;51:974-978.
34. Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HSV, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 1993;364:626-632.
35. Feelisch M. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J Cardiovasc Pharmacol. 1991;17(suppl 3):S25-S33.
36. Feelisch M, Ostrowski J, Noack E. On the mechanism of NO release from sydnonimines. J Cardiovasc Pharmacol. 1989;14(suppl 11);S13-S22.
37. McCleverty JA. Reactions of nitric oxide coordinated to transition metals. Chem Rev. 1979;79:53-76.
38. Stamler JS. Redox signaling: nitrosylation and related target inter-actions of nitric oxide. Cell. 1994;78:931-936.
39. Kim YM, Bergonia HA, Muller C, Pitt BR, Watkins WD, Lancaster JR Jr. Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis. J Biol Chem. 1995;270:5710-5713.
40. Hansson GK, Geng Y, Holm J, Hardhammar P, Wennmalm A, Jennische E. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J Exp Med. 1994;180:733-738.
41. Verbeurin TJ, Bonhomme E, Laubie M, Simonet S. Evidence for induction of nonendothelial NO synthase in aortas of cholesterol-fed rabbits. J Cardiovasc Pharmacol. 1993;21:841-845.
42. Klatt P, Schmidt K, Mayer B. Brain nitric oxide synthase is a haemoprotein. Biochem J. 1992;288:15-17.
43. Baek KJ, Thiel BA, Lucas S, Steuhr DJ. Macrophage nitric oxide synthase subunits: purification, characterization, and role of prosthetic groups and substrates in regulating their association into a dimeric enzyme. J Biol Chem. 1993;268:21120-21129.
44. Albakri QA, Stuehr DJ. Intracellular assembly of inducible NO synthase is limited by nitric oxide-mediated changes in heme insertion and availability. J Biol Chem. 1996;271:5414-5421.
45. Mathers G, Sherman MP, Buckberg GD, Haybron DM, Young HH, Ignarro LJ. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol. 1992;288:H616-H620.
46. Ma TT, Ishiroppoulos H, Brass CA. Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion. Gastroenterology. 1995;108:453-469.
47. Stocker R, Yamamoto Y, McDonagh AF, Gazer AN, Ames BN. Bilirubin is an antioxidant of possible physiologic importance. Science. 1987;235:1043-1046.
48. Neuzil J, Stocker R. Bilirubin attenuates radical-mediated damage to serum albumin. FEBS Lett. 1993;331:281-284.
49. Neuzil J, Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem. 1994;269:16712-16719.